Patients with cancer ‘well protected’ with double COVID-19 vax dose
A study is underway, however, to determine optimum coverage for people with compromised immunity
Patients with cancer can be reassured that two doses of COVID-19 vaccine provide a good level of protection against the virus, the CEO of Cancer Australia says, despite moves in some countries to offer a third dose.
Before the US announced a plan for universal booster shots in August, the Centers for Disease Control had recommended a third dose for patients receiving active cancer treatment for tumours or haematological cancers.
